As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing cancer.

SEATTLE — High demand for weight loss drugs like Ozempic and Wegovy has led to the emergence of "knockoff" versions that may not be as safe as the FDA-approved, brand-name versions. The ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

KUOW is Seattle’s NPR news station. We are an independent, nonprofit news organization that produces award-winning journalism, innovative podcasts, engaging community events, and more.

“These drugs promote substantial weight loss, reducing obesity-related cancer ... researcher at the Fred Hutchinson Cancer Center in Seattle. Anne McTiernan, MD, PhD “There have been trials ...

Wegovy® (the same drug as Ozempic rebranded for an obesity ... (5) For example, the clinics’ website promoted “Seattle Zepbound Weight Loss Program,” but defendants were not dispensing ...

Efforts to model the weight-loss drugs’ future impact are ... at the University of Washington in Seattle. Trials show that drugs such as semaglutide allow people to lose around 15% of their ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new analysis finds. Newer medications, such as Mounjaro and Wegovy, exhibit both more ...

The study couldn't explain that difference, but Mavromatis noted that differences in blood drug concentration, weight loss, metabolism or hormones could be at play. The Associated Press Health and ...